Recruitment And Diversity

31. How "Atomic Habits" Can Help Optimize Patient Recruitment 1/31/2025

    With the third article in his series “Inspired Patient Recruitment — Taking Inspiration from Business Advice Bestsellers," Ross Jackson applies theories from "Atomic Habits" by James Clear to clinical trial patient recruitment.

32. FDA Issues Draft Guidance: Study Of Sex Differences In The Clinical Evaluation Of Medical Products 1/29/2025

    The U.S. FDA's recent draft guidance on the Study of Sex Differences in the Clinical Evaluation of Medical Products deduces that individuals whose sex is assigned as “female” at birth are underrepresented in clinical trials. The public comment period ends April 7 (in theory), though it should be noted that the guidance was removed from the FDA website shortly after the new administration took office.

33. What Does It Mean To Be "Underserved"? 1/8/2025

    Learn what makes someone "underserved," understand the importance of that person's participation in research, learn about the barriers to them doing so, and discover ways to improve their inclusion.

34. Feels Like Home: Designing Sites For Patient Comfort 12/18/2024

    Cold, stark, and purely functional, healthcare settings have long lacked the comfort and familiarity of home — until now. Uncommon Cures has used the science of hope to inspire its cozy, comfortable new trial site.

35. Sick, Well, Or Somewhere In Between: Understanding The Patient Decision To Enroll In A Clinical Trial 12/18/2024

    Participating in clinical research involves profoundly personal and practical psychosocial considerations. Clinical Behavioral Healthcare Specialist Emily Epstein explains.

36. I AM INCLUDED: 8 Best Practices For Sites To Drive More Inclusive Clinical Trials 12/13/2024

    Discover the I AM INCLUDED framework, along with the actionable practices it provides to help all types of clinical trial sites extend the reach of their research.

37. Leveraging RWD With AI To Enable Diverse Recruitment In Clinical Trials 12/11/2024

    A diverse cohort of clinical research participants is vital to developing studies that are representative of the target population. Real-world data (RWD) can be paired with AI to integrate unstructured data.

38. Diversifying Diabetes Trials with DAPs, Omics, And Community Engagement 12/10/2024

    General practitioner and medical director Dr. Luke Twelves emphasizes the importance of more inclusive clinical trials, discussing the role of -omics and the potential impact of FDA-mandated diversity action plans (DAPs).

39. Seeing Firsthand The Transformative Impact Of AI On Pharmacovigilance And Clinical Research 11/27/2024

    Consultants Aashna Goyal and Guriqbal Singh share first-persona accounts of how AI is transforming pharmacovigilance and clinical research by improving data processing, enhancing decision-making, and accelerating drug development.

40. Patient Weighs Altruism, Self-Preservation, And Historical Mistrust In Decision To Enroll In Trial 11/22/2024

    In part three of this series on underserved patient enrollment, patient advocate Bill Allen shares why he enrolled in a clinical trial for both himself and the Black community.